Matt Muscio

Chief Executive Officer

With over 20 years of experience in the medical technology industry, Matt leads EBOS Medical Technology (EBOS MedTech), a leading medical device and biotechnologies platform across Australia, New Zealand, and Southeast Asia including LifeHealthcare, Australian Biotechnologies, Transmedic, and Cryomed.

Matt joined EBOS MedTech in May 2022 following the acquisition of the LifeHealthcare group from Pacific Equity Partners. Matt led LifeHealthcare as CEO since 2015, expanding the group into new therapeutic areas and geographies via organic and acquisitive strategies, under both publicly listed and private equity ownership.

Matt’s strategic and operational expertise has seen LifeHealthcare and now EBOS MedTech, establish a unique regional medical technology distribution platform with market-leading positions in Spine, Orthopaedics, Plastics and Reconstructive surgery, Neurovascular Therapies, Cardiology, and Allograft technologies.

Before LifeHealthcare, Matt was the Sales and Marketing Director for DePuy Synthes Spine and Codman.

As a board member of the MTAA (Medical Technologies Association of Australia) for over 5 years, Matt has played an active role in shaping policy and government advocacy for the industry.

Matt currently serves as a board member for Kunovus Technologies, a spinal nucleus replacement technology platform, providing the board and Kunovus team with governance and commercial expertise.